Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

Prostate cancer (PCa) affects millions of men globally. Due to advances in understanding genomic landscapes and biological functions, the treatment of PCa continues to improve. Recently, various new classes of agents, which include next-generation androgen receptor (AR) signaling inhibitors (abirate...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yundong, Xu, Weidong, Xiao, Yu-Tian, Huang, Haojie, Gu, Di, Ren, Shancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232569/
https://www.ncbi.nlm.nih.gov/pubmed/35750683
http://dx.doi.org/10.1038/s41392-022-01042-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232569/
https://www.ncbi.nlm.nih.gov/pubmed/35750683
http://dx.doi.org/10.1038/s41392-022-01042-7

Ejemplares similares